Hemagen Diagnostics Inc (HMGN)

Ticker: HMGN Exchange: OTC


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Buy 31 Jul 2012
Value US$4,036,586.96 | Price 24.66 | Shares 57,434 (-41.3%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2012-08-01 2012-07-31 B Purchase HALES WILLIAM P

Chairman, President & CEO

Executive Director Large shareholder
57,434 -41.3%
24.66
US$4,036,587
57,434 -41.3% 24.66 US$4,036,587
2011-04-08 2011-04-06 B Purchase HALES WILLIAM P

Chairman, President & CEO

Executive Director Large shareholder
66,947 -49.4%
231.43
US$3,446,415
66,947 -49.4% 231.43 US$3,446,415
2006-08-31 2006-08-30 B Purchase HALES WILLIAM P

Chairman, President & CEO

Executive Director Large shareholder
33,982 +2.9%
361.88
US$2,832,515
33,982 +2.9% 361.88 US$2,832,515
2006-01-04 2005-12-30 S Sale COHEN ALAN SEYMOUR Non-Executive Director
7,000 -3.0%
0.21
US$1,470
7,000 -3.0% 0.21 US$1,470
2005-11-03 2005-11-02 PP Planned purchase COHEN ALAN SEYMOUR Non-Executive Director
8,182 +14.1%
0.24
US$1,964
8,182 +14.1% 0.24 US$1,964
2005-11-03 2005-11-02 PP Planned purchase EDWARDS RICHARD W Non-Executive Director
8,182 +18.2%
0.24
US$1,964
8,182 +18.2% 0.24 US$1,964
2005-11-03 2005-11-02 PP Planned purchase LUTZ EDWARD Non-Executive Director
8,182 +18.8%
0.24
US$1,964
8,182 +18.8% 0.24 US$1,964
2005-08-12 2005-08-10 PP Planned purchase LUTZ EDWARD Non-Executive Director
6,188 +16.5%
0.32
US$1,980
6,188 +16.5% 0.32 US$1,980
2005-08-12 2005-08-10 PP Planned purchase EDWARDS RICHARD W Non-Executive Director
6,188 +15.9%
0.32
US$1,980
6,188 +15.9% 0.32 US$1,980
2005-08-12 2005-08-10 PP Planned purchase COHEN ALAN SEYMOUR Non-Executive Director
6,188 +12.0%
0.32
US$1,980
6,188 +12.0% 0.32 US$1,980
2005-06-20 2005-06-16 PP Planned purchase LUTZ EDWARD Non-Executive Director
12,111 +47.8%
0.33
US$3,985
12,111 +47.8% 0.33 US$3,985
2005-06-20 2005-06-16 PP Planned purchase COHEN ALAN SEYMOUR Non-Executive Director
12,111 +30.6%
0.33
US$3,985
12,111 +30.6% 0.33 US$3,985
2005-06-20 2005-06-16 PP Planned purchase EDWARDS RICHARD W Non-Executive Director
12,111 +45.3%
0.33
US$3,985
12,111 +45.3% 0.33 US$3,985
2004-07-23 2004-07-22 PP Planned purchase
2,856 +12.7%
0.70
US$1,999
2,856 +12.7% 0.70 US$1,999
2004-07-23 2004-07-22 PP Planned purchase
2,856 +7.8%
0.70
US$1,999
2,856 +7.8% 0.70 US$1,999
2004-07-23 2004-07-22 PP Planned purchase
2,856 +12.0%
0.70
US$1,999
2,856 +12.0% 0.70 US$1,999
2004-05-11 2004-05-07 PP Planned purchase
2,610 +12.3%
0.77
US$2,010
2,610 +12.3% 0.77 US$2,010
2004-05-11 2004-05-07 PP Planned purchase
2,610 +7.7%
0.77
US$2,010
2,610 +7.7% 0.77 US$2,010
2004-05-11 2004-05-07 PP Planned purchase
2,610 +13.1%
0.77
US$2,010
2,610 +13.1% 0.77 US$2,010
2004-02-03 2004-01-30 PP Planned purchase EDWARDS RICHARD W
2,913 +15.9%
0.69
US$2,010
2,913 +15.9% 0.69 US$2,010
2004-02-03 2004-01-30 PP Planned purchase LUTZ EDWARD
2,913 +17.2%
0.69
US$2,010
2,913 +17.2% 0.69 US$2,010
2004-02-03 2004-01-30 PP Planned purchase COHEN ALAN SEYMOUR
2,913 +9.3%
0.69
US$2,010
2,913 +9.3% 0.69 US$2,010
2004-02-03 2004-01-30 PP Planned purchase CURD HOWARD F
2,913 +7.3%
0.69
US$2,010
2,913 +7.3% 0.69 US$2,010
2004-01-06 2004-01-02 PP Planned purchase EDWARDS RICHARD W Non-Executive Director
13,873 +308.3%
0.58
US$7,998
13,873 +308.3% 0.58 US$7,998
2004-01-06 2004-01-02 PP Planned purchase CURD HOWARD F Non-Executive Director
13,873 +53.7%
0.58
US$7,998
13,873 +53.7% 0.58 US$7,998
2004-01-06 2004-01-02 PP Planned purchase LUTZ EDWARD Non-Executive Director
6,937 +69.4%
0.58
US$3,999
6,937 +69.4% 0.58 US$3,999
2004-01-06 2004-01-02 PP Planned purchase COHEN ALAN SEYMOUR Non-Executive Director
13,873 +8.1%
0.58
US$7,998
13,873 +8.1% 0.58 US$7,998
Explore more

More insider trading research around Hemagen Diagnostics Inc